Status:
UNKNOWN
Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice
Lead Sponsor:
Care Partners
Collaborating Sponsors:
OHSU Knight Cancer Institute
Oregon Health and Science University
Conditions:
Cancer Metastatic
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Feasibility study to report on the impact of ACCESS of single-fraction radiation therapy on cancer patients with bone metastases enrolled in hospice care.
Detailed Description
Hospice care for terminally ill patients with metastatic cancer improves quality of life, pain control, and potentially also survival when patients are enrolled early.1-3 However, hospice programs are...
Eligibility Criteria
Inclusion
- Solid Tumor Malignancies and Multiple Myeloma with Bone Metastases and Associated Bone Pain Enrolled in Hospice
Exclusion
- Decisionally-Impaired Subjects, Pregnant Women
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04049188
Start Date
January 1 2020
End Date
December 31 2021
Last Update
January 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CarePartners
Hillsboro, Oregon, United States, 97006